Ortoma is awarded with a European grant

Published January 25, 2013

Vinnova has awarded Ortoma with a EUREKA grant of €180 000.
EUREKA is a European inter-governmental initiative, with the objective of raising the productivity and competitiveness of European businesses through technology. It also aims to boost national economies on the international market and to strengthen the basis for sustainable prosperity and employment in Europe.
To meet the needs of restoring biomechanics in orthopedic surgery, Prof Matts Andersson and his experienced R&D team, have developed a treatment solution including a 3D preoperative software program – Ortoma Plan; and an easy-to-use intraoperative navigation system – Ortoma Guide. The EUREKA grant will be used to finalize development and validattion of Ortoma Guide.
”The EUREKA grant gives Ortoma an opportunity to provide orthopedic surgeons with a solution that may lead to improved and more precise outcomes. We now expect a market launch in 2013”,  says Mrs. Petra Apell, business developer at Ortoma.
For more information: dev.ortoma.com

About Ortoma AB (publ)
Ortoma AB develops surgical systems for the planning and positioning of implants in hip, knee and spinal surgery. The purpose of the company’s surgical system, Ortoma Treatment Solution™ (OTS) is to enable surgeons to accurately measure and plan 3D surgery for the placement of joint implants, and during surgery, to optimally position the implant in the patient. Ortoma’s surgical system is aimed at providing better patient outcomes, fewer complications and less follow-up surgeries – and thus better long-term survival rates for implants. OTS is a system that is easily integrated into the processes and routines currently used in surgery, thereby increasing efficiency. Globally, more than 7.5 million orthopedic procedures are performed each year where OTS could be used in hip, knee and spinal surgery. In Sweden, around 42,000 surgical procedures were performed last year, involving hip, knee or spinal surgery. Ortoma’s B shares are listed on Nasdaq First North Growth Market Stockholm.